Cyclodextrin-siRNA conjugates as versatile gene silencing agents

Cryan, 2004, Cationic cyclodextrin amphiphiles as gene delivery vectors, J. Drug Deliv. Sci. Technol., 14, 57, 10.1016/S1773-2247(04)50006-0 Evans, 2015, Cyclodextrin mediated delivery of NF-kappaB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro, Gene Ther., 22, 802, 10.1038/gt.2015.50 Fitzgerald, 2015, The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics, Biomaterials, 66, 53, 10.1016/j.biomaterials.2015.07.019 Fitzgerald, 2016, A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor, Int. J. Pharm., 499, 131, 10.1016/j.ijpharm.2015.12.055 Gaziova, 2014, Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect, Bioorg. Med. Chem., 22, 2320, 10.1016/j.bmc.2014.02.004 Godinho, 2013, Self-assembling modified beta-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease, Mol. Pharm., 10, 640, 10.1021/mp3003946 Godinho, 2014, Differential nanotoxicological and neuroinflammatory liabilities of non-viral vectors for RNA interference in the central nervous system, Biomaterials, 35, 489, 10.1016/j.biomaterials.2013.09.068 Gooding, 2015, Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis, Eur. J. Pharm. Sci., 71, 80, 10.1016/j.ejps.2015.02.007 Gooding, 2016, Oligonucleotide conjugates - candidates for gene silencing therapeutics, Eur. J. Pharm. Biopharm., 107, 321, 10.1016/j.ejpb.2016.07.024 Gunasekaran, 2011, Conjugation of siRNA with comb-type PEG enhances serum stability and gene silencing efficiency, Macromol. Rapid Commun., 32, 654, 10.1002/marc.201000804 Guo, 2011, Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?, Biotechnol. Adv., 29, 402, 10.1016/j.biotechadv.2011.03.003 Guo, 2012, Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice, Biomaterials, 33, 7775, 10.1016/j.biomaterials.2012.07.012 Iversen, 2013, Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice, Theranostics, 3, 201, 10.7150/thno.5743 Jung, 2010, Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight, J. Control. Release, 144, 306, 10.1016/j.jconrel.2010.03.002 Kole, 2012, RNA therapeutics: beyond RNA interference and antisense oligonucleotides, Nat. Rev. Drug Discov., 11, 125, 10.1038/nrd3625 Malhotra, 2009, Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells, Drug Dev. Ind. Pharm., 35, 719, 10.1080/03639040802526789 Malhotra, 2011, Small interfering ribonucleic acid design strategies for effective targeting and gene silencing, Expert Opin. Drug Discovery, 6, 269, 10.1517/17460441.2011.555394 Mendez-Ardoy, 2011, Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery, Nanomedicine, 6, 1697, 10.2217/nnm.11.59 O'Mahony, 2012, Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery, ACS Chem. Neurosci., 3, 744, 10.1021/cn3000372 O'Mahony, 2012, A click chemistry route to 2-functionalised PEGylated and cationic beta-cyclodextrins: co-formulation opportunities for siRNA delivery, Org. Biomol. Chem., 10, 4954, 10.1039/c2ob25490e O'Mahony, 2012, Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications, Eur. J. Pharm. Sci., 47, 896, 10.1016/j.ejps.2012.08.020 O'Mahony, 2013, Cyclodextrins for non-viral gene and siRNA delivery, Pharm. Nanotechnol., 1, 6, 10.2174/2211738511301010006 Park, 2013, Reducible hyaluronic acid−siRNA conjugate for targeted specific gene silencing, Bioconjug. Chem., 24, 1201, 10.1021/bc4001257 Rozema, 2007, Dynamic PolyConjugates for targeted in-vivo delivery of siRNA to hepatocytes, Proc. Natl. Acad. Sci. U. S. A., 104, 12982, 10.1073/pnas.0703778104 Sallas, 2008, Amphiphilic cyclodextrins – advances in synthesis and supramolecular chemistry, Eur. J. Org. Chem., 2008, 957, 10.1002/ejoc.200700933 Shokrzadeh, 2014, Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents, Bioorg. Med. Chem. Lett., 24, 5758, 10.1016/j.bmcl.2014.10.045 Singh, 2010, Effect of nanoparticle conjugation on gene silencing by RNA interference, J. Am. Chem. Soc., 132, 8241, 10.1021/ja102132e Tang, 2008, Facile synthesis of mono-6-amino-6-deoxy-[alpha]-, [beta]-, [gamma]-cyclodextrin hydrochlorides for molecular recognition, chiral separation and drug delivery, Nat. Protoc., 3, 691, 10.1038/nprot.2008.37 Wong, 2012, Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in-vivo, Nucleic Acid Ther., 22, 380, 10.1089/nat.2012.0389